Insufficient scRNA-seq data for expression of DLGAP5 at single-cell level.
Insufficient scRNA-seq data for expression of DLGAP5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 84% | 1141.81 | 1519 / 1809 | 87% | 20.16 | 412 / 472 |
intestine | 51% | 182.27 | 493 / 966 | 95% | 23.61 | 499 / 527 |
esophagus | 41% | 259.26 | 596 / 1445 | 98% | 33.59 | 180 / 183 |
lung | 50% | 95.62 | 289 / 578 | 88% | 21.81 | 1014 / 1155 |
stomach | 42% | 141.15 | 152 / 359 | 95% | 22.16 | 271 / 286 |
bladder | 14% | 17.33 | 3 / 21 | 93% | 25.05 | 468 / 504 |
ovary | 10% | 28.19 | 18 / 180 | 94% | 19.02 | 403 / 430 |
uterus | 6% | 9.48 | 10 / 170 | 97% | 37.61 | 446 / 459 |
breast | 15% | 19.78 | 70 / 459 | 87% | 18.88 | 977 / 1118 |
lymph node | 0% | 0 | 0 / 0 | 100% | 39.91 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 41.96 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.75 | 1 / 1 |
spleen | 95% | 383.73 | 229 / 241 | 0% | 0 | 0 / 0 |
pancreas | 4% | 4.70 | 13 / 328 | 73% | 10.32 | 130 / 178 |
peripheral blood | 69% | 1328.10 | 639 / 929 | 0% | 0 | 0 / 0 |
liver | 12% | 28.03 | 27 / 226 | 41% | 4.78 | 165 / 406 |
adrenal gland | 34% | 41.57 | 87 / 258 | 13% | 2.21 | 29 / 230 |
brain | 1% | 0.73 | 18 / 2642 | 33% | 5.56 | 234 / 705 |
thymus | 9% | 12.53 | 60 / 653 | 16% | 7.04 | 97 / 605 |
kidney | 12% | 32.31 | 11 / 89 | 11% | 1.32 | 97 / 901 |
prostate | 9% | 12.02 | 21 / 245 | 14% | 1.26 | 69 / 502 |
adipose | 20% | 27.33 | 237 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 10% | 0.69 | 8 / 80 |
blood vessel | 9% | 10.09 | 125 / 1335 | 0% | 0 | 0 / 0 |
heart | 6% | 8.33 | 49 / 861 | 0% | 0 | 0 / 0 |
muscle | 1% | 0.78 | 8 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051642 | Biological process | centrosome localization |
GO_0051382 | Biological process | kinetochore assembly |
GO_0007346 | Biological process | regulation of mitotic cell cycle |
GO_0007059 | Biological process | chromosome segregation |
GO_0007079 | Biological process | mitotic chromosome movement towards spindle pole |
GO_0045842 | Biological process | positive regulation of mitotic metaphase/anaphase transition |
GO_0023052 | Biological process | signaling |
GO_0007052 | Biological process | mitotic spindle organization |
GO_0072686 | Cellular component | mitotic spindle |
GO_0005737 | Cellular component | cytoplasm |
GO_0031616 | Cellular component | spindle pole centrosome |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0008017 | Molecular function | microtubule binding |
Gene name | DLGAP5 |
Protein name | DLG associated protein 5 Disks large-associated protein 5 (DAP-5) (Discs large homolog 7) (Disks large-associated protein DLG7) (Hepatoma up-regulated protein) (HURP) |
Synonyms | KIAA0008 DLG7 |
Description | FUNCTION: Potential cell cycle regulator that may play a role in carcinogenesis of cancer cells. Mitotic phosphoprotein regulated by the ubiquitin-proteasome pathway. Key regulator of adherens junction integrity and differentiation that may be involved in CDH1-mediated adhesion and signaling in epithelial cells. . |
Accessions | ENST00000247191.7 [Q15398-2] ENST00000554067.1 Q15398 G3V543 G3V4E5 ENST00000557645.5 ENST00000395425.6 [Q15398-3] |